Wu, Yuan
Zhou, Xuefeng
Zhao, Weiqing
Wang, Qiong
Han, Zhengxiang
Wang, Lifeng
Zhou, Wenjie
Zhou, Tong
Song, Haizhu
Chen, Yong
Yang, Kaihua
Shi, Lin
Pan, Banzhou
Guo, Renhong
Zhou, Guoren
Jiang, Feng
Feng, Jifeng
Shen, Bo
Funding for this research was provided by:
the China International Medical Foundation Project (Z-2014-06-2103)
the Project of Jiangsu Cancer Hospital (ZJ202110)
the National Natural Science Foundation of China (82272863)
Beijing Medical and Health Foundation Project (YWJKJJHKYJJ-F2030E)
the Huilan Public Interest Project (HL-HS-2020102)
Article History
Received: 22 August 2023
Accepted: 26 September 2023
First Online: 14 October 2023
Declarations
:
: The authors declare no competing interests.
: This trial complied with the Declaration of Helsinki (2000) of the World Medical Association. It had approval from the Ethics Committee of the Jiangsu Cancer Hospital. Signed informed consent was provided by each patient. The study was registered at the Chinese clinical trial registry (ExternalRef removed, ChiCTR1800019421).
: Signed informed consent was provided by each patient.
: N/A.
: N/A.